Vælg din region

Vælg den region, der bedst passer til din placering eller dine præferencer.

International

Vælg dit webstedssprog

Denne indstilling styrer sproget for brugergrænsefladen, inklusive knapper, menuer og al tekst på webstedet. Vælg dit foretrukne sprog for den bedste browsingoplevelse.

Vælg sprog for jobannoncer

Vælg de sprog for jobannoncer, du vil se. Denne indstilling afgør, hvilke jobannoncer der vises for dig.

qSTAR Medical

Paris, Frankrig

Abonner på nye stillinger

Besøg website

Om arbejdsgiveren

qSTAR Medical aims to improve the lives of patients suffering from End Stage Renal Disease (ESRD) by developing an innovative vascular access device featuring STAR® Biomaterial.

qSTAR Medical SAS was established in late 2011 as a spinout of Healionics USA with the support of OSEO France to develop a needle-free percutaneous port system for improved, pain-free and cost-effective vascular access for hemodialysis (HD) therapy.

There are approximately 20 million patients worldwide who suffer from Chronic Kidney Disease (CKD). An estimated 10% of these patients (2m) have progressed to the severe loss of kidney function defined as End Stage Renal Disease (ESRD) which requires life-sustaining thrice-weekly or daily dialysis therapy. Vascular access is the "Achilles heel" of hemodialysis therapy due to its high complication rates. ESRD patients need and deserve better vascular access options – qSTAR was created to help.